Article thumbnail

Effect of a fat spread enriched with medium-chain triacylglycerols and a special fatty acid-micronutrient combination on cardiometabolic risk factors in overweight patients with diabetes

By Roswitha Siener, Christina Ehrhardt, Norman Bitterlich and Christine Metzner
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1996). A: The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy? J Lipid Res
  2. (2002). Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation
  3. (2009). C: A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Asia Pac J Clin Nutr
  4. (2003). Carob pulp preparation rich in insoluble fiber lowers total and LDL cholesterol in hypercholesterolemic patients.
  5. (1991). Contaldo F: Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and longchain triglycerides.
  6. (2001). Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women.
  7. (2010). Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors, and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab
  8. (2003). Effects of margarine containing mediumchain triacylglycerols on body fat reduction in humans. J Atheroscler Thromb
  9. (1987). Excretion of dicarboxylic acids following administration if medium chain triglycerides. J Parenter Enteral Nutr
  10. (2007). Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem
  11. (1992). Feeding behavior in rats fed diets containing medium chain triglyceride. Physiol Behav
  12. (2010). Kelly DS: Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids.
  13. (2007). Mensink RP: Customary use of plant Siener et al.
  14. (2007). Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia
  15. (2003). Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration.
  16. (2008). PE: The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus.
  17. (2003). PJH: Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res
  18. (1990). Rowe WB: Medium-chaintriglyceride lipid emulsion: Metabolism and tissue distribution.
  19. (2009). S: Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism
  20. (2003). Short term effects of dietary medium-chain fatty acids and n-3 longchain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Lipids Health Dis
  21. (2008). Sipova I: High-sensitivity Creactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome. Med Sci Monit
  22. (2006). Stankova B: N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
  23. (2009). T: Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care
  24. (1980). The possible antiketogenic and gluconeogenic effects of the beta-oxidation of fatty acids in rats. Biochim Biophys Acta
  25. (2002). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Circulation
  26. (1999). Thorpe SR: Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes
  27. (1996). Twenty-four-hour energy expenditure and urinary catecholamines of humans consuming low-tomoderate amounts of medium-chain triglycerides: a dose-response study in a human respiratory chamber.
  28. (2009). Vitamin D supplementation enhances beneficial effects of weight loss on cardiovascular risk markers.
  29. (2005). Wood IS: Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans